The MB3000-PH is a high performance and versatile FT-IR spectrometer for the pharmaceutical industry. The result of more than 40 years experience in infrared spectroscopy, the MB3000-PH combines the analytical performance of a research grade spectrometer, with the ruggedness of an industrial analyzer.
ABB presents the new MB3000-PH, a high performance and versatile FT-IR spectrometer for the pharmaceutical industry.
The result of more than 35 years experience in infrared spectroscopy, the MB3000-PH combines the analytical performance of a research-grade spectrometer with the ruggedness of an industrial analyzer.
The reputation for excellence with ABB spectrometers is continued with the MB3000-PH that offers an outstanding signal-to-noise ratio.
The MB3000-PH has a standard open-sample compartment with removable purge tubes that allows to use a wide variety of infrared accessories, like ATR cells, transmission cells, diffuse reflectance accessories, gas cells, or microscopes.
The MB3000-PH features the brand new Horizon MB software suite. The suite contains several modules designed for maximum ease of use and simplicity.
Horizon MB FT-IR is the core module that allows to perform acquisition, analysis, and processing of spectra.
In addition, it includes an extensive health-monitoring interface.
The Horizon MB library module offers powerful library research capability for a variety of custom or commercial infrared spectra libraries.
The Horizon MB security module enables operation of the spectrometer in a 21 CFR Part 11 compliant environment.
This module offers two selectable security levels and provides hierarchical access control, electronic signatures for data access and approval.
It also provides logging of user actions and software events and traceability of all electronic record manipulations with data versioning.
Installation and validation of the instrument are straightforward, thanks to the complete set of installation qualification and operational qualification documents that also include regulatory statements for compliance with international pharmacopeia guidelines on use of infrared spectroscopy and 21 CFR Part 11 requirements for electronic records.
An important feature of the MB3000-PH is its extremely low cost of ownership, as it has permanently aligned and non-hydroscopic optics, and there are no consumables to replace for over 10 years.
The MB3000-PH represents the latest evolution in FT-IR spectroscopy for the life sciences industry.